132 related articles for article (PubMed ID: 17827752)
1. Synthesis and cytotoxicity of indolopyrrolemaleimides.
Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
Wang K; Li XY; Chen XG; Liu ZZ
J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.
Wang K; Liu ZZ
J Asian Nat Prod Res; 2014; 16(3):296-303. PubMed ID: 24456252
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of novel 3-amino-4-indolylmaleimide derivatives.
Zhao SY; Yang YW; Zhang HQ; Yue Y; Fan M
Arch Pharm Res; 2011 Apr; 34(4):519-26. PubMed ID: 21544716
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-methyl-bisindolylmaleimide amino acid methyl ester conjugates and cytotoxicity study.
Wang K; Liu ZZ
Eur J Med Chem; 2010 Sep; 45(9):4175-9. PubMed ID: 20598779
[TBL] [Abstract][Full Text] [Related]
8. Synthetic inhibitors of DNA topoisomerase I and II.
Katayama H; Kawada Y; Kaneko K; Oshiyama T; Takatsu N
Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):48-53. PubMed ID: 9987826
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
Katoh M; Dodo K; Fujita M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
Park HJ; Lee HJ; Lee EJ; Hwang HJ; Shin SH; Suh ME; Kim C; Kim HJ; Seo EK; Lee SK
Biosci Biotechnol Biochem; 2003 Sep; 67(9):1944-9. PubMed ID: 14519980
[TBL] [Abstract][Full Text] [Related]
11. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
12. A new concise synthesis of arcyriacyanin A and its unique inhibitory activity against a panel of human cancer cell line.
Murase M; Watanabe K; Yoshida T; Tobinaga S
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):81-4. PubMed ID: 10705481
[TBL] [Abstract][Full Text] [Related]
13. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and protein kinase C inhibition of arylpyrrolylmaleimides.
Xu GQ; Zhang C; Zhang L; Zhou XL; Yang B; He QJ; Hu YZ
Arch Pharm (Weinheim); 2008 May; 341(5):273-80. PubMed ID: 18404777
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents.
Lee H; Jeong I; Yang SI
Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX
Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885
[TBL] [Abstract][Full Text] [Related]
19. Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.
Xie G; Gupta R; Atchison K; Lown JW
J Med Chem; 1996 Mar; 39(5):1049-55. PubMed ID: 8676340
[TBL] [Abstract][Full Text] [Related]
20. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
